Clinical Trials Browser

OTHER × Melanoma × Dasatinib × Clear all

NCT01876212 2019-08-22

Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma

Phase 2 Completed

15 enrolled 26 charts

Melanoma, Neoplasm Metastasis

NCT00597038 2013-12-16

A Phase I/II Study of Dasatinib and Dacarbazine

Phase 1/2 Completed

50 enrolled 11 charts

Melanoma